We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$413M
AUM Growth
-$3.2M
Cap. Flow
-$14.3M
Cap. Flow %
-3.47%
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$23.5M
2
LIN icon
Linde
LIN
+$8.45M
3
V icon
Visa
V
+$5.42M
4
ALC icon
Alcon
ALC
+$3.14M
5
TMUS icon
T-Mobile US
TMUS
+$3.04M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.6%
2 Technology 15.24%
3 Industrials 9.82%
4 Financials 7.82%
5 Healthcare 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLMN icon
76
Bloomin' Brands
BLMN
$680M
$1.1M 0.27%
+52,513
New +$1.11M
EA icon
77
Electronic Arts
EA
$52.4B
$1.1M 0.27%
8,340
+7,564
+975% +$1.02M
ESMT
78
DELISTED
EngageSmart, Inc.
ESMT
$1.1M 0.27%
+45,605
New +$1.26M
SMG icon
79
ScottsMiracle-Gro
SMG
$4.03B
$1.09M 0.26%
+6,799
New +$1.05M
FWRD icon
80
Forward Air
FWRD
$482M
$1.09M 0.26%
+9,007
New +$922K
DHI icon
81
D.R. Horton
DHI
$41B
$1.07M 0.26%
9,883
+9,522
+2,638% +$917K
GILD icon
82
Gilead Sciences
GILD
$161B
$1.07M 0.26%
14,748
+586
+4% +$40.4K
EHC icon
83
Encompass Health
EHC
$11.2B
$1.07M 0.26%
20,524
+17,162
+510% +$885K
QCOM icon
84
Qualcomm
QCOM
$176B
$1.06M 0.26%
5,818
+3,583
+160% +$574K
EL icon
85
Estee Lauder
EL
$29B
$1.06M 0.26%
2,869
+2,865
+71,625% +$972K
CGNX icon
86
Cognex
CGNX
$10.3B
$1.05M 0.25%
13,511
+13,508
+450,267% +$1.09M
CB icon
87
Chubb
CB
$140B
$1.03M 0.25%
5,308
-2,076
-28% -$390K
GPN icon
88
Global Payments
GPN
$22.1B
$1.02M 0.25%
+7,570
New +$1.04M
PIPP.U
89
DELISTED
Pine Island Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
PIPP.U
$1.02M 0.25%
100,395
CADE
90
DELISTED
Cadence Bank
CADE
$1.02M 0.25%
+34,180
New +$1.03M
T icon
91
AT&T
T
$165B
$1.02M 0.25%
54,770
+33,897
+162% +$634K
FANG icon
92
Diamondback Energy
FANG
$57.6B
$1.01M 0.24%
9,376
+9,346
+31,153% +$1.01M
DGX icon
93
Quest Diagnostics
DGX
$25.1B
$1,000K 0.24%
5,780
-214
-4% -$32.6K
MRNA icon
94
Moderna
MRNA
$21.5B
$998K 0.24%
3,931
+1,577
+67% +$461K
PAVE icon
95
Global X US Infrastructure Development ETF
PAVE
$14.3B
$984K 0.24%
34,190
+6,490
+23% +$180K
NOACU
96
DELISTED
Natural Order Acquisition Corp. Unit
NOACU
$963K 0.23%
95,000
GS icon
97
Goldman Sachs
GS
$313B
$956K 0.23%
2,499
+873
+54% +$346K
AAL icon
98
American Airlines Group
AAL
$9.58B
$955K 0.23%
+53,188
New +$1.02M
NKE icon
99
Nike
NKE
$61.9B
$942K 0.23%
5,650
-1,187
-17% -$196K
MSOS icon
100
AdvisorShares Pure US Cannabis ETF
MSOS
$864M
$933K 0.23%
+36,460
New +$1.01M

Similar funds

Exane Derivatives's Q4 2021 Portfolio in Review

As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Exane Derivatives withdrew a net $14.3M in Q4 2021, closing 247 positions and reducing 309 holdings. Its most notable exit was Visa, an estimated $5.42M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Exane Derivatives opened a new position in EngageSmart, Inc. worth $1.1M.

  • Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
  • Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
  • Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
  • Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
  • Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
  • Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
  • Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.